Elicio Therapeutics, Inc.
USD3.08
+0.04 (+1.32%)
CEO
Robert T. Connelly
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.08
Prev. Close
$3.04
Day Low
$3.03
Day High
$3.16
52W Low
$2.66
52W High
$16.00
Market Cap
$0.06B
Volume
0.24M
| 52,832 |
| $3.20 |
| 17 Jul 2026 | Shah Preetam | See Remarks | A-Award | Acquired | 60,833 | $3.20 |
| 17 Jul 2026 | Connelly Robert | director, officer: CEO, President and Director | A-Award | Acquired | 186,944 | $3.20 |
| 3 Feb 2026 | Connelly Robert | director, officer: CEO, President and Director | A-Award | Acquired | 73,600 | $0.00 |
| 3 Feb 2026 | Connelly Robert | director, officer: CEO, President and Director | A-Award | Acquired | 147,200 | $8.10 |
| 3 Feb 2026 | Shah Preetam | See Remarks | A-Award | Acquired | 47,900 | $8.10 |
| 3 Feb 2026 | Shah Preetam | See Remarks | A-Award | Acquired | 24,000 | $0.00 |
| 3 Feb 2026 | DeMuth Peter | Chief Scientific Officer | A-Award | Acquired | 20,800 | $0.00 |
| 3 Feb 2026 | DeMuth Peter | Chief Scientific Officer | A-Award | Acquired | 41,600 | $8.10 |